| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.6M | — | -18.4% |
| Cost of Revenue | $2.2M | — | -16.5% |
| Gross Profit | $401K | — | -27.5% |
| R&D Expense | $17K | — | — |
| SG&A Expense | $859K | — | +25.3% |
| Operating Income | -$1.6M | — | -137.2% |
| Interest Expense | $175K | — | -27.4% |
| Pre-tax Income | -$1.8M | — | -95.2% |
| Net Income | -$1.8M | — | -95.2% |
| EPS (Basic) | -$0.12 | — | -9.1% |
| EPS (Diluted) | -$0.12 | — | -9.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $0 | — | — |
| Accounts Receivable | $1.1M | -16.6% | -24.3% |
| Inventory | $4.0M | +68.8% | +153.2% |
| Current Assets | $7.7M | +36.1% | +33.6% |
| Total Assets | $17.2M | +18.8% | +21.7% |
| Current Liabilities | $8.8M | +41.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.1M | — | -8.8% |
| Capital Expenditures | $515K | — | +36.4% |
| Investing Cash Flow | -$515K | — | -36.4% |
| Financing Cash Flow | $3.0M | — | +26.1% |
| Free Cash Flow | -$2.6M | — | -13.3% |
| +3.7% |
| Total Liabilities | $11.2M | +26.5% | +9.9% |
| Stockholders' Equity | $5.9M | +6.5% | +52.9% |